CPA4 and gastric cancer: Further analysis showed that the elevated expression of CPA4 in gastric cancers was significantly associated with tumor size, stage, lymph node metastasis, depth of invasion and distant metastasis, suggesting its use as a biomarker for the prognosis of the disease.